NLRP3 and metabolic syndrome: These results suggest that BV may have potential for use as a natural and cost-effective anti-inflammation agent or nutraceutical for preventing and ameliorating inflammation- and NLRP3 inflammasome-related diseases, including metabolic syndrome.